Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) saw unusually-high trading volume on Monday . Approximately 73,004 shares traded hands during trading, an increase of 182% from the previous session’s volume of 25,887 shares.The stock last traded at $171.67 and had previously closed at $170.92.
First Trust NYSE Arca Biotechnology Index Fund Stock Performance
The company’s 50 day moving average price is $165.44 and its 200-day moving average price is $156.12. The stock has a market cap of $1.30 billion, a P/E ratio of 17.20 and a beta of 0.86.
Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund
Large investors have recently modified their holdings of the stock. Gateway Wealth Partners LLC lifted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 3.8% during the second quarter. Gateway Wealth Partners LLC now owns 1,656 shares of the company’s stock valued at $255,000 after purchasing an additional 61 shares during the last quarter. WealthShield Partners LLC grew its stake in First Trust NYSE Arca Biotechnology Index Fund by 1.8% in the 2nd quarter. WealthShield Partners LLC now owns 3,714 shares of the company’s stock valued at $572,000 after buying an additional 66 shares in the last quarter. TD Capital Management LLC raised its holdings in First Trust NYSE Arca Biotechnology Index Fund by 6.4% during the 2nd quarter. TD Capital Management LLC now owns 1,141 shares of the company’s stock valued at $176,000 after acquiring an additional 69 shares during the period. Waverly Advisors LLC lifted its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 1.3% during the first quarter. Waverly Advisors LLC now owns 7,917 shares of the company’s stock worth $1,217,000 after acquiring an additional 100 shares in the last quarter. Finally, Pine Valley Investments Ltd Liability Co boosted its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 3.1% in the second quarter. Pine Valley Investments Ltd Liability Co now owns 3,444 shares of the company’s stock worth $530,000 after acquiring an additional 102 shares during the period.
About First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
Featured Stories
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- Are Penny Stocks a Good Fit for Your Portfolio?
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.